GlassScriptPhysician profile
Euclid Desouza
NPI 1609879733
$7,934.84
in general payments reported to CMS, 2019-2025
42 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,960 · 2020: $523 · 2021: $1,240 · 2022: $1,689 · 2023: $868 · 2024: $458 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.64 |
| Education | $119.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $2,070.30 | 2019-2021 | |
| Abbvie INC. | $1,018.18 | 2019-2025 | Botox, Lupron Depot, Synthroid |
| Astellas Pharma US INC | $637.36 | 2019-2023 | Xtandi |
| Janssen Biotech, INC. | $487.14 | 2019-2025 | Erleada, Akeega |
| Accord Healthcare, INC. | $450.94 | 2022-2025 | |
| Coloplast Corp | $304.54 | 2021-2024 | Porges Coloplast |
| Teleflex LLC | $280.26 | 2021-2023 | Urolift |
| Verity Pharmaceuticals INC. | $237.65 | 2022-2024 | Trelstar, Tlando |
| Boston Scientific Corporation | $233.25 | 2019-2024 | Spaceoar Vue System - 10ml |
| Myovant Sciences INC. | $211.52 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $201.02 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $195.48 | 2023-2024 | Orgovyx |
| Urogen Pharma, INC. | $179.96 | 2021-2025 | Jelmyto |
| Axonics, INC. | $151.06 | 2020-2023 | Axonics |
| Urovant Sciences INC | $132.51 | 2021-2022 |
Show all 41 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Euclid Desouza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.